Infection Surveillance Solutions Market PPT 2024: Size, Growth, Demand and Forecast till 2032
                     Global Infection 
Surveillance Solutions 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A cc o r d i ng  t o  t h e  l a t e s t  r e po r t  b y  IM A R C  G r o up ,  t i t l e d  " I n f e c t i o n  S u r v e i l l a n ce  
S o l u t i o n s  M a r ke t :  G l o b a l  In d u s t r y  T r e n d s ,  S h a re ,  S i z e ,  G r o w t h ,  O p p o r t u n i t y  a n d  
F o r e c a s t  2 0 2 4 - 20 3 2 , "  t h e  g l o b a l  i n f e c t i o n  s u r v e i l l a n ce  s o l u t i on s  m a r k e t  s i z e  re a c h e d  
U S $  6 5 2 . 6  M i l l i o n  i n  2 02 3 .
Report Fac tors  A f fec t ing  the  Growth  o f  t he  In fect ion  Surve i l lance  So lu t ions  Indust ry :Increas ing  Preva lence  o f  Hea l thcare -Assoc ia t ed  In f ec t ions  (HA Is ) :
T he  g ro w t h  o f  t he  i n f e c t i o n  su r v e i l l a n ce  s o l u t i o n s  i n d us t r y  i s  s i g n i f i ca n t l y  d r i ve n  by  t he  
Highlight and r i s i n g  p r e v a l e n c e  o f  he a l t h ca r e - a ss o c i a t ed  i n f e c t i on s  ( H A Is ) .  A d d i t i o n a l l y ,  h o s p i ta l s  
an d  he a l t h c a r e  f a c i l i t i e s  a re  u nd e r  i n c r ea s i n g  p r e s s u re  t o  m i n i m i ze  H A I s  du e  t o  t h e i r  
i mp a c t  o n  p a t i e n t  o u tc o m es  a nd  h ea l t h ca r e  co s t s .  I n fe c t i o n  s u r v e i l l a n ce  s o l u t i o ns  
Description p r o v i d e  r ea l - t i m e  mo n i t o r i n g ,  d a t a  an a l y s i s ,  a n d  re p o r t i ng  c a p a b i l i t i e s  t h a t  h e l p  
he a l t h c a re  p r ov i d e r s  i d e n t i f y  a n d  r e s p o nd  t o  i n fe c t i o n  o u t b re a k s  p r o m p t l y .  
T he s e  s ys t e m s  e n a b l e  t h e  i m p l em e n t a t i o n  o f  e f f e c t i ve  i n f e c t i o n  co n t r o l  m e as u r e s ,  
en s u r i n g  c o m p l i an c e  w i th  r e g u l a t o r y  s t a n da r d s  a n d  i m p r ov i n g  pa t i e n t  s a fe t y .  A s  t he  
i n c i d e n c e  o f  H A I s  c o n t i n ue s  t o  p o s e  a  m a j o r  ch a l l e n g e  g l ob a l l y ,  t h e r e  h a s  b e e n  a  r i s e  
i n  d e m an d  f o r  r o b u s t  i n f e c t i o n  s u r v e i l l a n ce  s o l u t i o n s ,  d r i v i n g  i n d u s t r y  e x pa n s i o n .
Str ingent  Regulatory  Requi rements  and Standards:
St r in gen t  r eg u la t o r y  r e qu i r em en t s  and  s t and a r ds  a im ed  a t  r educ in g  HAI s  a r e  k ey  
f ac t o r s  p r op e l l i ng  t he  g r ow t h  o f  t h e  i n f e c t i o n  su r ve i l l anc e  so lu t i ons  i ndus t r y .  
Regu la t o r y  bod ies  su ch  a s  t h e  Cen t e r s  f o r  D i se ase  Co n t r o l  and  P r e ven t i on  ( C DC)  
and  t h e  Wor ld  He a l t h  O r g an iza t i on  ( WHO )  m and a t e  s t r i c t  in f ec t i on  c on t r o l  p r o t o co l s  
Report and  r egu la r  r e po r t in g  o f  i n f e c t i on  da t a .  
Com p l i anc e  w i t h  t hes e  r eg u la t i o ns  r e qu i r es  hea l t hca r e  f ac i l i t i es  t o  a dop t  a dvanc ed  
su r v e i l l anc e  so lu t i ons  t ha t  o f f e r  accu r a t e  a nd  com pr e hens i ve  i n f ec t i on  t r ack in g  a nd  
Highlight and r epo r t i ng  capa b i l i t i es .  M or eo ve r ,  t hese  s o lu t i on s  he lp  h ea l t h ca r e  p r ov id e r s  m ee t  
r egu la t o r y  r eq u i r em en t s ,  avo id  pena l t i es ,  a nd  enh ance  t he i r  r epu t a t i on  f o r  pa t i en t  
Description sa f e t y .  The  g r o w ing  em ph as i s  on  r e gu la t o r y  com p l ia nce  and  qua l i t y  ass u r anc e  i n  hea l t hca r e  i s  d r i v i ng  t he  adop t i on  o f  i n f ec t i o n  su r ve i l l an ce  so lu t i o ns .
Technologica l  Advancements:
Tech no log i ca l  a dvanc em e n t s  and  i n t eg r a t i on  c apab i l i t i es  i n  i n f ec t i on  su r ve i l l an ce  
so lu t i ons  a r e  c r uc ia l  d r i ve r s  o f  i n dus t r y  g r ow t h .  I nnova t i ons  such  a s  a r t i f i c i a l  
i n t e l l i gence  ( A I ) ,  m ach ine  l ea r n in g ,  and  b ig  d a t a  ana l y t i c s  have  r evo lu t i on i zed  
i n f e c t i on  su r ve i l l anc e  by  enab l i ng  p r ed i c t i v e  an a l y t i c s ,  au t om a t ed  da t a  p r o cess i ng ,  
and  ea r l y  de t e c t i on  o f  i n f ec t i on  t r ends .
These  techno log ies  enhance  the  accuracy  and  e f f i c iency  o f  in fec t ion  t rack ing ,  
a l l ow ing  fo r  t ime ly  in te rven t ions  and  be t te r  resource  a l l oca t ion .  Add i t iona l ly ,  
the  in teg ra t ion  o f  in fec t ion  su rve i l l ance  so lu t ions  w i th  e lec t ron ic  hea l th  
reco rds  (EHRs) ,  l abora to ry  in fo rma t ion  sys tems (L IS ) ,  and  o ther  hea l thca re  IT  
sys tems c rea tes  a  seamless  da ta  f l ow,  improv ing  the  overa l l  e f fec t i veness o f  
Report i n fec t ion  con t ro l  p rog rams.  The  con t inuous  advancement  and  in teg ra t ion  o f  these  techno log ies  a re  fos te r ing  the  w idesp read  adop t ion  o f  i n fec t ion  
su rve i l lance  so lu t ions .
Highlight and 
Request  for  a  PDF sample  o f  th is  repor t :  
Description h t tps : / /www. imarcgroup .com/ in fec t ion -su rve i l l ance -so lu t ions -marke t / reques tsa
mp le
Report Description
Global  In fect ion  Surve i l lance Solut ions Market  Trends:
The  g loba l  i n fec t ion  su rve i l l ance  so lu t ions  marke t  i s  exper ienc ing  s ign i f i can t  g rowt h  d r i ven  by  t he  inc reas ing  adop t ion  
o f  advanced  hea l t hca re  I T  sys t ems  and  t he  r i s ing  focus  on  pa t ien t  sa f e t y .  Key  t r ends  inc lude  the  in tegra t ion  o f  
a r t i f i c i a l  i n te l l i gence  (A I )  and  mach ine  lea rn ing  t o  enhance  p red ic t i ve  ana l y t i cs  and  ear l y  de tec t ion  o f  i n f ec t ion  
pa t t e rns .  The  sh i f t  t oward  c loud-based  so lu t ions  i s  ga in ing  t rac t ion  due  to  the i r  sca lab i l i t y ,  cos t -e f fec t i veness ,  and  
rea l - t ime  da ta  access  capab i l i t i es .  
Add i t i ona l l y ,  t here  i s  a  g rowing  emphas is  on  comp l iance  w i th  s t r ingen t  regu la to ry  requ i remen ts  and  s tandards ,  
p rope l l i ng  the  demand f o r  robus t  i n fec t ion  su rve i l l ance  sys t ems.  The  m arke t  i s  w i tness ing  inc reased  inves t men t s  in  
in t e roperab i l i t y ,  enab l i ng  seamless  in teg ra t ion  w i th  e lec t ron ic  hea l th  reco rds  (EHRs)  and o the r  hea l thca re  in fo rma t ion  
sys tem s,  f u r ther  enhanc ing  the  e f fec t i veness  o f  i n fec t ion  con t ro l  p rog rams ,  and fu r t he r  p rope l l i ng  the  marke t  g rowth .
Look ing  fo rward ,  the  market  i s  an t ic ipated  to  reach  a  va lue  o f  US$  1 , 314 .8  Mi l l i on  by  2032,  exh i b i t i ng  a  CAGR 
of  7 .65% dur i ng  2024-2032 .
V i ew Report  TOC,  F igures and  Tab les :  h t tps: / / www. i marcgroup .com/ i n fect ion -survei l l ance-so l u t ions-market
Breakup by Component:
• Software
• Services
Breakup by Deployment Type:
Report • On-premises
• Cloud-based
Segmentation
Breakup by End User:
• Hospita ls
• Clinics
• Ambulatory Service Centers
• Specialty Centers
• Others
Breakup by Region:
• North America
Report • Asia-Pacifi c
Segmentation • Europe
• Latin America
• Middle East and Afr ica
• Baxter International Inc.
• Becton Dickinson and Company
• Centrak Inc.  (Halma plc)
• Cerner Corporation
Competitive • CKM Healthcare Incorporated
Landscape • Ecolab Inc.
• International Business Machines Corporation
with Key 
• Medexter Healthcare
Players • Perahealth Inc.
• PointClickCare
• Premier Inc.
• Sunquest Information Systems Inc. (Roper 
Technologies Inc.)
What was the size of the global infection surveillance 
solutions market in 2023?
What is the expected growth rate of the global infection 
surveillance solutions market during 2024-2032?
What are the key factors driving the global infection 
surveillance solutions market?
Key 
What has been the impact of COVID-19 on the global 
infection surveillance solutions market?
Questions 
What is the breakup of the global infection surveillance 
Answered in solutions market based on the component?
the Report What is the breakup of the global infection surveillance 
solutions market based on the deployment type?
What is the breakup of the global infection surveillance 
solutions market based on the end user?
What are the key regions in the global infection surveillance 
solutions market?
Who are the key players/companies in the global infection 
surveillance solutions market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  I n f e c t i o n  S u r v e i l l a n c e  S o l u t i o n s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  C o m p o n e n t
    6 . 1     S o f t w a r e
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     S e r v i c e s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  D e p l o y m e n t  T y p e
    7 . 1     O n - p r e m i s e s
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
       
    7 . 2     C l o u d - b a s e d
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  E n d  U s e r
    8 . 1     H o s p i t a l s
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     C l i n i c s
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     A m b u l a t o r y  S e r v i c e  C e n t e r s
        8 . 3 . 1  M a r k e t  T r e n d s
Table of         8 . 3 . 2  M a r k e t  F o r e c a s t    8 . 4     S p e c i a l t y  C e n t e r s
        8 . 4 . 1  M a r k e t  T r e n d s
        8 . 4 . 2  M a r k e t  F o r e c a s t
Contents     8 . 5     O t h e r s        8 . 5 . 1  M a r k e t  T r e n d s
        8 . 5 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  R e g i o n
    9 . 1     N o r t h  A m e r i c a
        9 . 1 . 1  U n i t e d  S t a t e s
           9 . 1 . 1 . 1  M a r k e t  T r e n d s
           9 . 1 . 1 . 2  M a r k e t  F o r e c a s t
        9 . 1 . 2  C a n a d a
           9 . 1 . 2 . 1  M a r k e t  T r e n d s
           9 . 1 . 2 . 2  M a r k e t  F o r e c a s t
    9 . 2     A s i a - P a c i f i c
        9 . 2 . 1  C h i n a
           9 . 2 . 1 . 1  M a r k e t  T r e n d s
           9 . 2 . 1 . 2  M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / in f e c t i o n - s u r v e i l l a n c e - s o l u t i o n s - m
a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: